Berikutnya

Putar otomatis

Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia

7 Tampilan • 08/04/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Oliver Ottmann (Goethe-University Hospital, Frankfurt, Germany) discusses a Trial of the European Working Group for Adult ALL (EWALL-PH-02), which evaluated nilotinib and chemotherapy for first-line treatment in elderly patients with de novo Philadelphia chromosome/BCR-ABL1-positive acute lymphoblastic leukaemia.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis